A drug repurposing screen identifies altiratinib as a selective inhibitor of a key regulatory splicing kinase and a potential therapeutic for toxoplasmosis and malaria
Christopher Swale(Centre National de la Recherche Scientifique), Mohamed‐Ali Hakimi(Centre National de la Recherche Scientifique)
Cited by 1
Related Papers
<i>Toxoplasma</i>Effectors Targeting Host Signaling and Transcription
|Clinical Microbiology Reviews|2017|349
A <i>Toxoplasma</i> dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation
|The Journal of Experimental Medicine|2013|283
The Toxoplasma Dense Granule Proteins GRA17 and GRA23 Mediate the Movement of Small Molecules between the Host and the Parasitophorous Vacuole
|Cell Host & Microbe|2015|272
Histone-Modifying Complexes Regulate Gene Expression Pertinent to the Differentiation of the Protozoan Parasite <i>Toxoplasma gondii</i>
|Molecular and Cellular Biology|2005|197
Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites
|The Journal of Experimental Medicine|2009|188